Ardelyx's post-earnings decline attributed to concerns over Ibsrela outlook [Seeking Alpha]
Ardelyx: Strong IBSRELA Growth, But Heavy Operational Spend Clouds Profitability [Seeking Alpha]
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ardelyx Inc (ARDX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Developments ... [Yahoo! Finance]